894 related articles for article (PubMed ID: 17900656)
1. Increased expression of eotaxin-3 distinguishes between eosinophilic esophagitis and gastroesophageal reflux disease.
Bhattacharya B; Carlsten J; Sabo E; Kethu S; Meitner P; Tavares R; Jakate S; Mangray S; Aswad B; Resnick MB
Hum Pathol; 2007 Dec; 38(12):1744-53. PubMed ID: 17900656
[TBL] [Abstract][Full Text] [Related]
2. Interplay of adaptive th2 immunity with eotaxin-3/c-C chemokine receptor 3 in eosinophilic esophagitis.
Bullock JZ; Villanueva JM; Blanchard C; Filipovich AH; Putnam PE; Collins MH; Risma KA; Akers RM; Kirby CL; Buckmeier BK; Assa'ad AH; Hogan SP; Rothenberg ME
J Pediatr Gastroenterol Nutr; 2007 Jul; 45(1):22-31. PubMed ID: 17592361
[TBL] [Abstract][Full Text] [Related]
3. Potential of blood eosinophils, eosinophil-derived neurotoxin, and eotaxin-3 as biomarkers of eosinophilic esophagitis.
Konikoff MR; Blanchard C; Kirby C; Buckmeier BK; Cohen MB; Heubi JE; Putnam PE; Rothenberg ME
Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1328-36. PubMed ID: 17059896
[TBL] [Abstract][Full Text] [Related]
4. Treatment with topical steroids downregulates IL-5, eotaxin-1/CCL11, and eotaxin-3/CCL26 gene expression in eosinophilic esophagitis.
Lucendo AJ; De Rezende L; Comas C; Caballero T; Bellón T
Am J Gastroenterol; 2008 Sep; 103(9):2184-93. PubMed ID: 18844613
[TBL] [Abstract][Full Text] [Related]
5. Tacrolimus decreases the expression of eotaxin, CCR3, RANTES and interleukin-5 in atopic dermatitis.
Park CW; Lee BH; Han HJ; Lee CH; Ahn HK
Br J Dermatol; 2005 Jun; 152(6):1173-81. PubMed ID: 15948978
[TBL] [Abstract][Full Text] [Related]
6. The spectrum of pediatric eosinophilic esophagitis beyond infancy: a clinical series of 30 children.
Orenstein SR; Shalaby TM; Di Lorenzo C; Putnam PE; Sigurdsson L; Mousa H; Kocoshis SA
Am J Gastroenterol; 2000 Jun; 95(6):1422-30. PubMed ID: 10894574
[TBL] [Abstract][Full Text] [Related]
7. Eosinophilic esophagitis and intermediate esophagitis after tracheoesophageal fistula repair: a case series.
Oliveira C; Zamakhshary M; Marcon P; Kim PC
J Pediatr Surg; 2008 May; 43(5):810-4. PubMed ID: 18485944
[TBL] [Abstract][Full Text] [Related]
8. Activated mucosal mast cells differentiate eosinophilic (allergic) esophagitis from gastroesophageal reflux disease.
Kirsch R; Bokhary R; Marcon MA; Cutz E
J Pediatr Gastroenterol Nutr; 2007 Jan; 44(1):20-6. PubMed ID: 17204948
[TBL] [Abstract][Full Text] [Related]
9. Enhanced expression of interleukin-8 and activation of nuclear factor kappa-B in endoscopy-negative gastroesophageal reflux disease.
Isomoto H; Saenko VA; Kanazawa Y; Nishi Y; Ohtsuru A; Inoue K; Akazawa Y; Takeshima F; Omagari K; Miyazaki M; Mizuta Y; Murata I; Yamashita S; Kohno S
Am J Gastroenterol; 2004 Apr; 99(4):589-97. PubMed ID: 15089887
[TBL] [Abstract][Full Text] [Related]
10. Increased esophageal regulatory T cells and eosinophil characteristics in children with eosinophilic esophagitis and gastroesophageal reflux disease.
Tantibhaedhyangkul U; Tatevian N; Gilger MA; Major AM; Davis CM
Ann Clin Lab Sci; 2009; 39(2):99-107. PubMed ID: 19429794
[TBL] [Abstract][Full Text] [Related]
11. Esophageal subepithelial fibrosis in children with eosinophilic esophagitis.
Chehade M; Sampson HA; Morotti RA; Magid MS
J Pediatr Gastroenterol Nutr; 2007 Sep; 45(3):319-28. PubMed ID: 17873744
[TBL] [Abstract][Full Text] [Related]
12. High intraepithelial eosinophil counts in esophageal squamous epithelium are not specific for eosinophilic esophagitis in adults.
Rodrigo S; Abboud G; Oh D; DeMeester SR; Hagen J; Lipham J; DeMeester TR; Chandrasoma P
Am J Gastroenterol; 2008 Feb; 103(2):435-42. PubMed ID: 18289205
[TBL] [Abstract][Full Text] [Related]
13. Analysis of symptoms and endoscopic findings in 117 patients with histological diagnoses of eosinophilic esophagitis.
Müller S; Pühl S; Vieth M; Stolte M
Endoscopy; 2007 Apr; 39(4):339-44. PubMed ID: 17427070
[TBL] [Abstract][Full Text] [Related]
14. Eosinophilic esophagitis: a prevalent disease in the United States that affects all age groups.
Kapel RC; Miller JK; Torres C; Aksoy S; Lash R; Katzka DA
Gastroenterology; 2008 May; 134(5):1316-21. PubMed ID: 18471509
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-8 expression in the esophageal mucosa of patients with gastroesophageal reflux disease.
Yoshida N; Uchiyama K; Kuroda M; Sakuma K; Kokura S; Ichikawa H; Naito Y; Takemura T; Yoshikawa T; Okanoue T
Scand J Gastroenterol; 2004 Sep; 39(9):816-22. PubMed ID: 15513378
[TBL] [Abstract][Full Text] [Related]
16. Correlation between number of eosinophils and reflux index on same day esophageal biopsy and 24 hour esophageal pH monitoring.
Steiner SJ; Gupta SK; Croffie JM; Fitzgerald JF
Am J Gastroenterol; 2004 May; 99(5):801-5. PubMed ID: 15128340
[TBL] [Abstract][Full Text] [Related]
17. Esophageal remodeling in pediatric eosinophilic esophagitis.
Aceves SS; Newbury RO; Dohil R; Bastian JF; Broide DH
J Allergy Clin Immunol; 2007 Jan; 119(1):206-12. PubMed ID: 17208603
[TBL] [Abstract][Full Text] [Related]
18. Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis.
Stein ML; Collins MH; Villanueva JM; Kushner JP; Putnam PE; Buckmeier BK; Filipovich AH; Assa'ad AH; Rothenberg ME
J Allergy Clin Immunol; 2006 Dec; 118(6):1312-9. PubMed ID: 17157662
[TBL] [Abstract][Full Text] [Related]
19. Reduction of interleukin 8 gene expression in reflux esophagitis and Barrett's esophagus with antireflux surgery.
Oh DS; DeMeester SR; Vallbohmer D; Mori R; Kuramochi H; Hagen JA; Lipham J; Danenberg KD; Danenberg PV; Chandrasoma P; DeMeester TR
Arch Surg; 2007 Jun; 142(6):554-9; discussion 559-60. PubMed ID: 17576892
[TBL] [Abstract][Full Text] [Related]
20. Apoptotic eosinophils in sputum from asthmatic patients correlate negatively with levels of IL-5 and eotaxin.
Xu J; Jiang F; Nayeri F; Zetterström O
Respir Med; 2007 Jul; 101(7):1447-54. PubMed ID: 17379492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]